These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
512 related articles for article (PubMed ID: 21813412)
1. The role of p27(Kip1) in dasatinib-enhanced paclitaxel cytotoxicity in human ovarian cancer cells. Le XF; Mao W; He G; Claret FX; Xia W; Ahmed AA; Hung MC; Siddik ZH; Bast RC J Natl Cancer Inst; 2011 Sep; 103(18):1403-22. PubMed ID: 21813412 [TBL] [Abstract][Full Text] [Related]
2. Dasatinib induces autophagic cell death in human ovarian cancer. Le XF; Mao W; Lu Z; Carter BZ; Bast RC Cancer; 2010 Nov; 116(21):4980-90. PubMed ID: 20629079 [TBL] [Abstract][Full Text] [Related]
3. CDK5 Regulates Paclitaxel Sensitivity in Ovarian Cancer Cells by Modulating AKT Activation, p21Cip1- and p27Kip1-Mediated G1 Cell Cycle Arrest and Apoptosis. Zhang S; Lu Z; Mao W; Ahmed AA; Yang H; Zhou J; Jennings N; Rodriguez-Aguayo C; Lopez-Berestein G; Miranda R; Qiao W; Baladandayuthapani V; Li Z; Sood AK; Liu J; Le XF; Bast RC PLoS One; 2015; 10(7):e0131833. PubMed ID: 26146988 [TBL] [Abstract][Full Text] [Related]
4. Inhibition of cell growth and up-regulation of MAD2 in human oesophageal squamous cell carcinoma after treatment with the Src/Abl inhibitor dasatinib. Wang L; Guo B; Wang R; Jiang Y; Qin S; Liang S; Zhao Y; Guo W; Li K; Fan X Clin Sci (Lond); 2012 Jan; 122(1):13-24. PubMed ID: 21751967 [TBL] [Abstract][Full Text] [Related]
5. Dasatinib sensitizes KRAS mutant colorectal tumors to cetuximab. Dunn EF; Iida M; Myers RA; Campbell DA; Hintz KA; Armstrong EA; Li C; Wheeler DL Oncogene; 2011 Feb; 30(5):561-74. PubMed ID: 20956938 [TBL] [Abstract][Full Text] [Related]
6. The role of lysyl oxidase in SRC-dependent proliferation and metastasis of colorectal cancer. Baker AM; Cox TR; Bird D; Lang G; Murray GI; Sun XF; Southall SM; Wilson JR; Erler JT J Natl Cancer Inst; 2011 Mar; 103(5):407-24. PubMed ID: 21282564 [TBL] [Abstract][Full Text] [Related]
7. Dasatinib, a small molecule inhibitor of the Src kinase, reduces the growth and activates apoptosis in pre-neoplastic Barrett's esophagus cell lines: evidence for a noninvasive treatment of high-grade dysplasia. Inge LJ; Fowler AJ; Paquette KM; Richer AL; Tran N; Bremner RM J Thorac Cardiovasc Surg; 2013 Feb; 145(2):531-8. PubMed ID: 23142123 [TBL] [Abstract][Full Text] [Related]
8. Ketoconazole potentiates the antitumor effects of nocodazole: In vivo therapy for human tumor xenografts in nude mice. Wang YJ; Jeng JH; Chen RJ; Tseng H; Chen LC; Liang YC; Lin CH; Chen CH; Chu JS; Ho WL; Ho YS Mol Carcinog; 2002 Aug; 34(4):199-210. PubMed ID: 12203371 [TBL] [Abstract][Full Text] [Related]
9. Targeting SRC in mucinous ovarian carcinoma. Matsuo K; Nishimura M; Bottsford-Miller JN; Huang J; Komurov K; Armaiz-Pena GN; Shahzad MM; Stone RL; Roh JW; Sanguino AM; Lu C; Im DD; Rosenshien NB; Sakakibara A; Nagano T; Yamasaki M; Enomoto T; Kimura T; Ram PT; Schmeler KM; Gallick GE; Wong KK; Frumovitz M; Sood AK Clin Cancer Res; 2011 Aug; 17(16):5367-78. PubMed ID: 21737505 [TBL] [Abstract][Full Text] [Related]
10. Activity of the multikinase inhibitor dasatinib against ovarian cancer cells. Konecny GE; Glas R; Dering J; Manivong K; Qi J; Finn RS; Yang GR; Hong KL; Ginther C; Winterhoff B; Gao G; Brugge J; Slamon DJ Br J Cancer; 2009 Nov; 101(10):1699-708. PubMed ID: 19861960 [TBL] [Abstract][Full Text] [Related]
11. Degradation of epidermal growth factor receptor mediates dasatinib-induced apoptosis in head and neck squamous cell carcinoma cells. Lin YC; Wu MH; Wei TT; Chuang SH; Chen KF; Cheng AL; Chen CC Neoplasia; 2012 Jun; 14(6):463-75. PubMed ID: 22787428 [TBL] [Abstract][Full Text] [Related]
12. Dasatinib inhibits site-specific tyrosine phosphorylation of androgen receptor by Ack1 and Src kinases. Liu Y; Karaca M; Zhang Z; Gioeli D; Earp HS; Whang YE Oncogene; 2010 Jun; 29(22):3208-16. PubMed ID: 20383201 [TBL] [Abstract][Full Text] [Related]
13. Dasatinib enhances antitumor activity of paclitaxel in ovarian cancer through Src signaling. Xiao J; Xu M; Hou T; Huang Y; Yang C; Li J Mol Med Rep; 2015 Sep; 12(3):3249-3256. PubMed ID: 25975261 [TBL] [Abstract][Full Text] [Related]
14. Src family kinase/abl inhibitor dasatinib suppresses proliferation and enhances differentiation of osteoblasts. Lee YC; Huang CF; Murshed M; Chu K; Araujo JC; Ye X; deCrombrugghe B; Yu-Lee LY; Gallick GE; Lin SH Oncogene; 2010 Jun; 29(22):3196-207. PubMed ID: 20228840 [TBL] [Abstract][Full Text] [Related]
15. HOXA10 expression induced by Abl kinase inhibitors enhanced apoptosis through PI3K pathway in CML cells. Sugimoto Y; Nakamura S; Okinaka K; Hirano I; Ono T; Shigeno K; Shinjo K; Ohnishi K Leuk Res; 2008 Jun; 32(6):962-71. PubMed ID: 18190961 [TBL] [Abstract][Full Text] [Related]
16. Peptidomimetic Src/pretubulin inhibitor KX-01 alone and in combination with paclitaxel suppresses growth, metastasis in human ER/PR/HER2-negative tumor xenografts. Anbalagan M; Ali A; Jones RK; Marsden CG; Sheng M; Carrier L; Bu Y; Hangauer D; Rowan BG Mol Cancer Ther; 2012 Sep; 11(9):1936-47. PubMed ID: 22784709 [TBL] [Abstract][Full Text] [Related]
17. miR-221 confers lapatinib resistance by negatively regulating p27 Huynh TK; Huang CH; Chen JY; Yao JH; Yang YS; Wei YL; Chen HF; Chen CH; Tu CY; Hsu YM; Liu LC; Huang WC Cancer Sci; 2021 Oct; 112(10):4234-4245. PubMed ID: 34382727 [TBL] [Abstract][Full Text] [Related]
18. Reduced miR-3127-5p expression promotes NSCLC proliferation/invasion and contributes to dasatinib sensitivity via the c-Abl/Ras/ERK pathway. Sun Y; Chen C; Zhang P; Xie H; Hou L; Hui Z; Xu Y; Du Q; Zhou X; Su B; Gao W Sci Rep; 2014 Oct; 4():6527. PubMed ID: 25284075 [TBL] [Abstract][Full Text] [Related]
19. Dasatinib (BMS-35482) has synergistic activity with paclitaxel and carboplatin in ovarian cancer cells. Teoh D; Ayeni TA; Rubatt JM; Adams DJ; Grace L; Starr MD; Barry WT; Berchuck A; Murphy SK; Secord AA Gynecol Oncol; 2011 Apr; 121(1):187-92. PubMed ID: 21208651 [TBL] [Abstract][Full Text] [Related]
20. Antitumor activity of UCN-01 in carcinomas of the head and neck is associated with altered expression of cyclin D3 and p27(KIP1). Patel V; Lahusen T; Leethanakul C; Igishi T; Kremer M; Quintanilla-Martinez L; Ensley JF; Sausville EA; Gutkind JS; Senderowicz AM Clin Cancer Res; 2002 Nov; 8(11):3549-60. PubMed ID: 12429646 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]